Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use

NAActive, not recruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

February 12, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Substance Use DisordersHiv
Interventions
BEHAVIORAL

Population level patient portal based substance involvement screening

Participants 18 years or older, with an active patient portal account, who have attended an HIV care clinic visit in the HIV clinic in the last two years and have not completed the validated National Institute for Drug Abuse (NIDA) Quick Screen V1.0 in the previous year will be eligible for intervention randomization. Those randomized into the intervention group will receive the validated NIDA Quick Screen V1.0 over their patient portal account. Participants randomized to this group can complete the screener over the patient portal without a scheduled appointment with their HIV clinician.

BEHAVIORAL

Usual Care Substance Use Involvement Screening

Participants randomized to the usual care group will receive the validated NIDA Quick Screen V1.0 during routine in-clinic visits if they attend their scheduled visit. The medical assistant will ask participants to complete the NIDA Quick Screen V1.0. Participants who endorse the use of illegal drugs or prescription drugs for non-medical reasons, tobacco use, or heavy drinking will be referred to SUD treatment.

Trial Locations (1)

60637

University of Chicago Medicine, Chicago

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Chicago

OTHER

NCT06682468 - Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance Use | Biotech Hunter | Biotech Hunter